These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 16554885

  • 1. [Insulin treatment in type 2 diabetes].
    Birkeland KI.
    Tidsskr Nor Laegeforen; 2006 Mar 23; 126(7):919-20. PubMed ID: 16554885
    [No Abstract] [Full Text] [Related]

  • 2. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
    Crasto W, Jarvis J, Hackett E, Nayyar V, McNally PG, Davies MJ, Lawrence IG.
    Postgrad Med J; 2009 Apr 23; 85(1002):219-22. PubMed ID: 19417173
    [Abstract] [Full Text] [Related]

  • 3. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
    Westphal SA, Palumbo PJ.
    Arch Intern Med; 2009 Apr 23; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
    [No Abstract] [Full Text] [Related]

  • 4. Switching from an oral regimen to insulin in diabetes.
    Perry M.
    Community Nurse; 2000 May 23; 6(4):27-8. PubMed ID: 12778520
    [No Abstract] [Full Text] [Related]

  • 5. [Cancer more common in diabetes. Maybe the treatment itself also plays a role].
    Nilsson PM, Eliasson B.
    Lakartidningen; 2000 May 23; 107(4):170-1. PubMed ID: 20333969
    [No Abstract] [Full Text] [Related]

  • 6. [Low carbohydrate diet slowed down the progression of renal insufficiency in type 2 diabetes. A case--difficult to draw conclusions].
    Vesti-Nielsen J, Westerlund P, Bygren P.
    Lakartidningen; 2000 May 23; 105(30-31):2094-7. PubMed ID: 18751447
    [No Abstract] [Full Text] [Related]

  • 7. Insulin glargine (Lantus) and cancer risk.
    Med Lett Drugs Ther; 2009 Aug 24; 51(1319):67-8. PubMed ID: 19696708
    [No Abstract] [Full Text] [Related]

  • 8. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.
    Currie CJ, Johnson JA.
    Diabetes Obes Metab; 2012 Jan 24; 14(1):1-4. PubMed ID: 21736688
    [Abstract] [Full Text] [Related]

  • 9. [Analog insulin requirements of the average patient. Interview by Dr. rer. nat. Anita Schweiger].
    Renner MR.
    Fortschr Med; 1997 Apr 10; 115(10):8-10. PubMed ID: 9206690
    [No Abstract] [Full Text] [Related]

  • 10. Overcoming barriers to insulin replacement.
    Kuritzky L.
    J Fam Pract; 2009 Aug 10; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract] [Full Text] [Related]

  • 11. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.
    Ballani P, Tran MT, Navar MD, Davidson MB.
    Diabetes Care; 2006 Nov 10; 29(11):2504-5. PubMed ID: 17065692
    [No Abstract] [Full Text] [Related]

  • 12. [Analog insulin preparations in patients with type 2 diabetes. Better rapid and brief than sluggish and long].
    MMW Fortschr Med; 2005 Nov 17; 147(46):60. PubMed ID: 16358638
    [No Abstract] [Full Text] [Related]

  • 13. [Hypoglycemia risk. Why elderly patients are especially at risk].
    Stiefelhagen P.
    MMW Fortschr Med; 2002 May 30; 144(22):10. PubMed ID: 12116563
    [No Abstract] [Full Text] [Related]

  • 14. [Gastrointestinal motility disorders and therapy. How diabetes paralyzes the intestine].
    MMW Fortschr Med; 2005 Feb 03; 147(5):8. PubMed ID: 15766015
    [No Abstract] [Full Text] [Related]

  • 15. [Current insulin therapy--avoidable errors].
    Mehnert H.
    Fortschr Med; 1998 Nov 10; 116(31):28-30, 32-3. PubMed ID: 9864893
    [Abstract] [Full Text] [Related]

  • 16. [Intensive insulin therapy to prevent the progression of chronic vascular complications in type 2 diabetes mellitus].
    Kishikawa H, Araki E, Wake N, Shichiri M.
    Nihon Rinsho; 2002 Sep 10; 60 Suppl 9():140-5. PubMed ID: 12386985
    [No Abstract] [Full Text] [Related]

  • 17. Insulin and type 2 diabetes--a simple guide to prevent 'stuff ups'.
    Phillips PJ.
    Aust Fam Physician; 2006 Dec 10; 35(12):975-8. PubMed ID: 17149472
    [No Abstract] [Full Text] [Related]

  • 18. Insulin glargine: cornerstone treatment for type 2 diabetes patients. Introduction.
    Garg SK.
    Diabetes Obes Metab; 2008 Jul 10; 10 Suppl 2():1-4. PubMed ID: 18577151
    [No Abstract] [Full Text] [Related]

  • 19. As the worm turns. On diabetes and obesity.
    Gottlieb SH.
    Diabetes Forecast; 2002 Apr 10; 55(4):25-7. PubMed ID: 14959687
    [No Abstract] [Full Text] [Related]

  • 20. Pan-insulin allergy and severe lipoatrophy complicating Type 2 diabetes.
    Tavare AN, Doolittle HJ, Baburaj R.
    Diabet Med; 2011 Apr 10; 28(4):500-3. PubMed ID: 21392071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.